Potent 20S proteasome inhibitor (IC50
= 0.22 nM). Exhibits cytostatic and cytotoxic effects in tumor cells in vitro
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Studies of the synthesis of all stereoisomers of MG-132 proteasome inhibitors in the tumor targeting approach.
Mroczkiewicz et al.